Phase 2 Start
KRRO: Phase 2 Start: A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study
September 1, 2026 · urea. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 1, 2026
- Company
- Korro Bio, Inc. (KRRO)
- Drug
- urea
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Start~month
Phase 2 Start: A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study
- Company
- Korro Bio, Inc. (KRRO)
- Drug
- urea
- Indication
- Ornithine Transcarbamylase (OTC) Deficiency; Arginase 1 Deficiency; Urea Cycle Disorders, Inborn